BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24252932)

  • 41. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs.
    Liu Z; Wei P; Yang Y; Cui W; Cao B; Tan C; Yu B; Bi R; Xia K; Chen W; Wang Y; Zhang Y; Du X; Zhou X
    Clin Cancer Res; 2015 Apr; 21(7):1752-63. PubMed ID: 25762344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 Expression Helps Identify High Risk Oral Tongue Pre- malignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases.
    Viveka TS; Shyamsundar V; Krishnamurthy A; Ramani P; Ramshankar V
    Asian Pac J Cancer Prev; 2016; 17(1):189-95. PubMed ID: 26838208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
    Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
    Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis.
    Wangsa D; Chowdhury SA; Ryott M; Gertz EM; Elmberger G; Auer G; Åvall Lundqvist E; Küffer S; Ströbel P; Schäffer AA; Schwartz R; Munck-Wikland E; Ried T; Heselmeyer-Haddad K
    Int J Cancer; 2016 Jan; 138(1):98-109. PubMed ID: 26175310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
    Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
    J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.
    Almangush A; Heikkinen I; Mäkitie AA; Coletta RD; Läärä E; Leivo I; Salo T
    Br J Cancer; 2017 Sep; 117(6):856-866. PubMed ID: 28751758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
    Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
    Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive role of Toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma.
    Mäkinen LK; Atula T; Häyry V; Jouhi L; Datta N; Lehtonen S; Ahmed A; Mäkitie AA; Haglund C; Hagström J
    Oral Oncol; 2015 Jan; 51(1):96-102. PubMed ID: 25264223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A simple novel prognostic model for early stage oral tongue cancer.
    Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
    Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Limonin suppresses the progression of oral tongue squamous cell carcinoma via inhibiting YAP transcriptional regulatory activity.
    Yang G; Li Z; Chen L
    Tissue Cell; 2020 Aug; 65():101346. PubMed ID: 32746992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
    Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
    Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival of oral tongue squamous cell carcinoma in young adults.
    Oliver JR; Wu SP; Chang CM; Roden DF; Wang B; Hu KS; Schreiber D; Givi B
    Head Neck; 2019 Sep; 41(9):2960-2968. PubMed ID: 30985036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluctuating role of antimicrobial peptide hCAP18/LL‑37 in oral tongue dysplasia and carcinoma.
    Vierthaler M; Rodrigues PC; Sundquist E; Siponen M; Salo T; Risteli M
    Oncol Rep; 2020 Jul; 44(1):325-338. PubMed ID: 32627035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I).
    Bello IO; Soini Y; Salo T
    Oral Oncol; 2010 Sep; 46(9):630-5. PubMed ID: 20637681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulation of heat shock protein 27 expression in oral tongue squamous cell carcinoma.
    Wang A; Liu X; Sheng S; Ye H; Peng T; Shi F; Crowe DL; Zhou X
    BMC Cancer; 2009 Jun; 9():167. PubMed ID: 19497117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical value of lymphatic vessel density, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 expression in patients with oral tongue squamous cell carcinoma.
    Yan J; Jiang Y; Ye M; Liu W; Feng L
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C125-30. PubMed ID: 25450269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral tongue squamous cell carcinoma in never-smokers: analysis of clinicopathologic characteristics and survival.
    Durr ML; van Zante A; Li D; Kezirian EJ; Wang SJ
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):89-96. PubMed ID: 23533221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
    Yang W; Wu B; Ma N; Wang Y; Guo J; Zhu J; Zhao S
    In Vitro Cell Dev Biol Anim; 2019 Jun; 55(6):445-452. PubMed ID: 31140101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.